RocketVax raised €6.7M in a Series A round in Aug 2021. The company is based in Basel, Switzerland. Investors in the round: Canton of Basel-Stadt, Innosuisse, University Hospital Basel. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
